Walnut Shell Glasses Moxibustion for Dry Eye Syndrome

• Status: Unknown status
• Trial end date: 2018-12-30
• Target enrollment: 0
• Participant gender: All

Summary

This trial is designed to evaluate the efficacy of walnut shell glasses moxibustion for dry eye syndrome compared with sodium hyaluronate eye drops.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences
• Treatments: Hyaluronic Acid; Methamphetamine; Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

1. eyes are in line with dry eye diagnostic criteria.

2. Age 18 to 75 years,

3. signed informed consent, voluntary adherence to treatment for more than 1 month.

Exclusion Criteria:

1. combined with other eye disease (such as conjunctiva, cornea and iris have significant lesions).

2. eye surgery within 3 months.

3. pregnant or lactating women.

4. oral the drugs which could inhibit lacrimal gland secretion.

5. severe meibomian gland dysfunction.

6. severe eye burns, chemical injury patients.

7. combined with cardiovascular and cerebrovascular, liver, kidney and hematopoietic system and other serious primary disease, mental patients.

8. patients with Sjogren's syndrome.

9. patients who are participating in other drug clinical trials.

10. patients who are using other drugs or therapies for the treatment of dry eyes.